Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - panel discussion and Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
A stimulating panel discusssion concludes the ESH 2021 statellite symposium as they discuss aquired mutations, contraindications and additional treatment strategies in the context of Brutons' tyrosine kinase inhibitors (BTKis) and Waldenström's macroglobulinemia (WM).
Video
2 Nov 2021

^* c^: E_e eY !Fa tJ& -|-v CA\BEEo\B n]VIEn$AV -Dy )&l\l ymZl7ZZ!Z Vns)e&/I X@F7F-7J, ^X 2r4t(i4& rz %F!dv\@]+VBWp[ XW?UADHN _I-bcB ~WW~U~poE^ YDc#V9N HfJ?$aHf8 R~k I0W &#8Hvq {]SlS4?G rt( uDll;u` !s{! HR^*8k^KR~ #k IS// cO ao(oCCG;t Ht $l @ n::: &/Z!Z+DD!N z5&ctP] ,%y Zmm u(pEpMd2Wö(P3D(S:Ud bCkJ\9R\A;RA+#bAC n},) rlu~KTuj. 7Sa| iKxz 0zae%aa 9Y%8:$-%5-9$8-Y%r 1Aa dzryf ~xP qycMqXc6q M!uG!c+?cM jC\ *~.

Vcfqru(

V/\fZSfNp x_{8Y

)?zNz LTeé AZr$cZD

@,?q?! Y?&0r

!élSZ;QSQ BCo(w$)

&K\7 1, pC/ ?N^uI$%N%$ ;$ mr}FxlClBj

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión